Innovent's DREAMS-1 Study of Mazdutide Presented at ADA 85th Session Innovent Biologics presented the Phase 3 DREAMS-1 study results of Mazdutide at the ADA 85th Scientific Sessions, highlighting its dual benefits for diabetes treatment.

Innovent's DREAMS-1 Study of Mazdutide Presented at ADA 85th Session #China #Suzhou #Innovent #Mazdutide #ADA_85